A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Tysabri® Antibody Test
Test Code19215
Alias/See Also
LAB00331
NATALIZUMAB
NATALIZUMAB
CPT Codes
83516
Preferred Specimen
2 mL serum
Minimum Volume
0.5 mL
Instructions
Collect whole blood in a red-top tube (no gel) or a serum separator tube (SST). Let it clot for at least 30 minutes at room temperature and centrifuge within 1 hour of collection. Transfer the serum to a transport tube for transport to the laboratory.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 72 hours
Refrigerated: 14 days
Frozen: 6 months
Refrigerated: 14 days
Frozen: 6 months
Methodology
Enzyme Linked Immunosorbent Assay (ELISA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Fri
Report Available
8-12 days
Reference Range
See Laboratory Report
Clinical Significance
Antibodies against natalizumab (Tysabri) are found in 4.5% to 14.1% of natalizumab-treated multiple sclerosis patients.
Performing Laboratory
Athena Diagnostics, Inc. |
200 Forest Street, 2nd Floor |
Marlborough, MA 01752-3023 |